✦ LIBER ✦

6501 ORAL Global Lung Oncology Branch trial 3 (GLOB 3): Quality of Life (QoL) results of a randomised multinational Phase III trial of oral and i.v. vinorelbine (NVB) plus cisplatin (CDDP) versus docetaxel (DTX) plus CDDP as first-line treatment for advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Rolski, J.; Grodzki, T.; Schneider, C.P.; Zatloukal, P.; Reck, M.; Aitini, E.; Tan, E.H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9091 Activity, safety and compliance of

✍ Teragni, C.; Palumbo, R.; Bernardo, A.; Strada, M.R.; Poggi, G.; Amatu, A.; Mont 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

P.40 Oral vinorelbine and gemcitabine (o

✍ Vamvakas, L.; Karampeazis, A.; Agelaki, S.; Agelidou, A.; Kotsakis, A.; Kakolyri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB